MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Microstructural Changes in the Inferior Tuberal Hypothalamus Correlate with Daytime Sleepiness in Lewy Body Disease

    J. Cohen, H. Radhakrishnan, C. Olm, S. Das, P. Cook, D. Wolk, D. Weintraub, D. Irwin, C. Mcmillan (Philadelphia, USA)

    Objective: Identify neuroimaging correlates of excessive daytime sleepiness in Lewy body disorders using diffusion MRI. Background: Excessive daytime sleepiness (EDS) is a common and disabling…
  • 2024 International Congress

    Optimal measuring height and validation of 2D-LiDAR based analysis system for spatiotemporal gait parameters

    S. Woo, C. Shin, MY. Kim (Daegu, Republic of Korea)

    Objective: This study aims to validate a 2D light detection and ranging (LiDAR) based gait analysis system with a reference system. In addition, the optimal…
  • 2024 International Congress

    Jaw Clonus Masquerading as Jaw Tremor in a case of Amyotrophic Lateral Sclerosis (ALS)

    A. Boddu (Little Rock, USA)

    Objective: To highlight the importance of distinguishing jaw clonus from jaw tremor which can be a useful sign in clinical diagnosis by reporting a case…
  • 2024 International Congress

    eHealth – an Opportunity for personalized Care? – Healthcare Professionals’ Technology Acceptance in the Care of Parkinson’s Patients

    J. Stuempel, J. Hohn, V. Fleckenstein, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)

    Objective: To examine how eHealth may improve personalized care for people with Parkinson's disease (PwPD) from the perspective of healthcare professionals (HCPs). Background: Parkinson's disease…
  • 2024 International Congress

    Balancing Act: Smartphone Data and Machine Learning in Movement Disorder Classification

    S. Macneille, A. Kostic, A. Chu, J. Daneault (Newark, USA)

    Objective: Determine if machine learning models can classify healthy individuals and people with movement disorders using smartphone data collected during a simple balance task. Background:…
  • 2024 International Congress

    Using LEAD-DBS to Identify the Optimal DBS Electrode in the Abbott Infinity System

    J. Karl, S. Dong, C. Taylor, N. Shetty, J. Rosenow, M. Nolt, L. Verhagen Metman (Chicago, USA)

    Objective: To determine whether the optimal electrode contact selected in Abbott deep brain stimulation (DBS) leads is the same using conventional versus image-guided programming (LEAD-DBS…
  • 2024 International Congress

    The Contribution of APOE4 Genotype on Structural MRI in Parkinson’s Disease: A Study from the PPMI Cohort

    A. Rosal, A. Strafella, S. Martin (Toronto, Canada)

    Objective: To assess the contribution of Apolipoprotein E4 (APOE4) in Parkinson’s Disease (PD)-related cognitive impairment by analyzing its impact on Gray Matter Volume (GMV). Background:…
  • 2024 International Congress

    Adaptive vs Conventional Chronic Deep Brain Stimulation: Results from a Randomized Pilot Trial in Parkinson’s Disease

    I. Isaias, S. Marceglia, L. Romito, R. Eleopra, L. Borellini, V. Levi, M. Locatelli, T. Mandat, E. Pirola, A. Ampollini, M. Lanotte, L. Lopiano, M. Zibetti, A. Bentivoglio, C. Piano, A. Izzo, F. Tamma, G. Foffani, A. Lozano, E. Moro, J. Volkmann, C. Conti, M. Arlotti, L. Krinke, L. Rossi, A. Priori (Milan, Italy)

    Objective: To assess the safety and efficacy of chronic adaptive (aDBS) and conventional (cDBS) deep brain stimulation of the subthalamic nucleus in patients with Parkinson’s…
  • 2024 International Congress

    Preliminary Efficacy of Bilateral Intraputaminal Delivery of GDNF Gene Therapy (AAV2-GDNF; AB-1005) in Parkinson’s Disease: 18-Month Follow-Up From a Phase 1b Study

    N. Phielipp, C. Christine, A. Merola, J. Elder, P. Larson, W. San Sebastian, M. Fiandaca, C. Urrea, M. Wisniewski, A. van Laar, A. Kells, K. Bankiewicz (Irvine, USA)

    Objective: To assess the preliminary efficacy of bilateral intraputaminal delivery of adeno-associated virus serotype 2 containing glial cell line–derived neurotrophic factor (AAV2-GDNF; AB-1005) for patients…
  • 2024 International Congress

    The Effects of Baduanjin on Fine Motor Skills in Mild and Moderate Parkinson’s Disease

    JUN. Li, KF. Li, HZ. Chen, WM. Yang (Hefei, China)

    Objective: To investigate whether Baduanjin Qigong exercise could help improve fine motor skills in patients with Parkinson's disease. Background: It is common for people with…
  • « Previous Page
  • 1
  • …
  • 330
  • 331
  • 332
  • 333
  • 334
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley